$PRPO News

Precipio, Inc. (PRPO) Q1 2026 Earnings Call Transcript

Precipio Q1 EPS $(0.81) Down From $(0.59) YoY, Sales $6.711M Up From $4.929M YoY

Precipio, Inc. (PRPO) Q4 2025 Earnings Call Prepared Remarks Transcript

Precipio Announces Q4 and year-end 2025 Shareholder Update Call

Precipio Announces Publication of a Joint Study with Memorial Sloan-Kettering Cancer Center Highlighting Its Cutting-Edge Bloodhound BCR::ABL1 Assay

Precipio Announces Data On New Bloodhound Assay For Chronic Myeloid Leukemia Published In Journal Of Clinical Pathology

Precipio Announces Data On New Bloodhound Assay For Chronic Myeloid Leukemia Published In Journal Of Clinical Pathology

Precipio 2025 (Unaudited) Revenues Grew to $24.0M, a 30% Increase Year-Over-Year

Precipio Q4 2025 Preliminary Revenue $6.7M, An Increase Of 23% From $5.4M YoY

Precipio Takes Major Steps Toward a Clean Balance Sheet

Precipio to Showcase its BCR::ABL1 panel at 2025 ASH (American Society of Hematology) Meeting

Precipio Identifies Unauthorized Access to Isolated Storage; No Operational Impact

Precipio Stock Up Following Solid Q3 Earnings and Improved Cash Flow

Precipio Inc (PRPO) Q3 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ...

Precipio, Inc. (PRPO) Q3 2025 Earnings Call Prepared Remarks Transcript

Precipio Announces its Q3-2025 Financial Results

Precipio Q3 EPS $(0.05) Up From $(0.42) YoY, Sales $6.767M Up From $5.209M YoY

Precipio Announces Q3-2025 Shareholder Update Call

Precipio Terminates Sales Agreement With A.G.P.

Precipio Terminates Its ATM